CYduct Diagnostics, Inc.
CYDX · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -16.3% | -29.2% | 26.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 66.2% | 67% | 69.9% | 67.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -513.8% | -448.5% | -369.7% | -177.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -585.1% | -494.8% | -396.1% | -447.1% |
| EPS Diluted | -0.079 | -0.08 | -0.093 | -0.082 |
| % Growth | 1.7% | 13.3% | -13.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |